Brief: Study Data From Castle Biosciences' Collaboration With The National Cancer Institute's SEER Program Registries Published In JCO Precision Oncology
30/06/2023 12:11
June 30 (Reuters) - Castle Biosciences Inc CSTL.O :
* STUDY DATA FROM CASTLE BIOSCIENCES’ COLLABORATION WITH THE
NATIONAL CANCER INSTITUTE’S SEER PROGRAM REGISTRIES PUBLISHED IN
JCO PRECISION ONCOLOGY
Source text for Eikon: ID:nBwbtlB12a
Further company coverage: CSTL.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Castle Biosciences
See all newsBrief: Castle Biosciences, - Opens New Laboratory And Office Facility In Scottsdale, Arizona
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Castle Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Castle Biosciences beats Q2 revenue estimates, hikes forecast
Brief: Castle Biosciences Q2 Revenue USD 103.546 Million Vs. IBES Estimate USD 86.2 Million